Effecot of Serratus Posterior Superior Intercostal Plane Block and Thoracic Paravertebral Block in VATS
Comparison of Postoperative Analgesic Efficacy of Serratus Posterior Superior Intercostal Plane Block and Thoracic Paravertebral Block in Patients Undergoing Video-Assisted Thoracoscopic Surgery
1 other identifier
interventional
70
1 country
1
Brief Summary
Video-assisted thoracoscopic surgery (VATS) has become a standard procedure in both minor and major lung surgeries in thoracic surgery operations. Although postoperative pain in patients undergoing VATS is not as severe as that seen after thoracotomy, it still occurs. This, in turn, affects postoperative pulmonary complications and patients\' lengths of hospital stay. Thoracic epidural analgesia (TEA) is still considered the gold standard in the treatment of postoperative pain. However, due to side effects such as post-procedural hypotension, urinary retention, or nausea/vomiting, alternative analgesic methods such as thoracic paravertebral block (TPVB), intercostal block, serratus anterior plane block (SAPB), erector spinae plane block (ESPB), and serratus posterior superior intercostal plane block (SPSIPB) are being considered instead of epidural analgesia. Among these methods, TPVB performed under ultrasound guidance is already a commonly preferred and classical method. In patients undergoing thoracotomy and VATS, Tulgar and colleagues have defined SPSIPB as a new technique and demonstrated its efficacy in providing analgesia in the hemithorax when considering the sensory dermatome of SPSIPB in a cadaveric and a case series study with five patients conducted in 2023. Similarly, Avcı and colleagues, in their article published in 2023, emphasized the analgesic effectiveness of SPSIPB in the thoracic region after VATS. As far as we know, there is no published study comparing TPVB and SPSIPB under ultrasound guidance to date. Therefore, the aim of this study was to compare ultrasound-guided TPVB and SPSIPB in postoperative analgesia after VATS. Our primary goal is to investigate whether there are any superiority in terms of postoperative Visual analog score (VAS), time to first rescue analgesia, opioid consumption, postoperative nausea and vomiting (PONV) score, and complications, and to determine which one is more effective.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 29, 2023
CompletedFirst Posted
Study publicly available on registry
January 23, 2024
CompletedStudy Start
First participant enrolled
January 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2024
CompletedJanuary 6, 2025
January 1, 2025
4 months
December 29, 2023
January 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperatative Pain
Evaluation of patients' post-operative pain levels
24 hours
Study Arms (2)
Group T
ACTIVE COMPARATORGroup T patients who underwent TPVB
Group S
ACTIVE COMPARATORGroup S patients who underwent SPSIPB
Interventions
SPSIPB Technique: The SPSIPB block, which follows the guidelines we routinely use, will be performed after the completion of the surgical procedure and before the patient wakes up. TPVB Technique: The US probe (11-12 MHz, Vivid Q) will be placed 2-3 cm lateral to the T5 spinous process. After visualizing the transverse process, the paravertebral area, internal intercostal membrane, paravertebral space, and pleura, the needle will be advanced to the paravertebral space using an in-plane technique.
Eligibility Criteria
You may qualify if:
- A minimum of 70 patients who will undergo VATS surgery,
- American Society of Anesthesiologists (ASA) physical classification 1-2-3,
- Aged between 18-65,
- Who have read and accepted the voluntary informed consent form,
- Body mass index (BMI) of \<35.
You may not qualify if:
- Patients who refuse to participate in the study,
- BMI \>35,
- ASA physical classifications 4-5,
- Patients unable to perform pain scoring using the NRS system,
- Those allergic to the administered local anesthetic and designated analgesic medication, individuals declaring pregnancy or lactation,
- Patients under 18 or over 65 years of age,
- Uncontrollable anxiety,
- Alcohol and drug addiction,
- Neuromuscular and peripheral nerve diseases,
- Using high doses of opioid medication three days before surgery,
- Widespread chronic pain,
- Diabetes mellitus,
- Hepatic and renal insufficiency,
- Coagulation disorders,
- Using anticoagulant drugs,
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hitit university
Çorum, Çorum, 19100, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Guvenc Dogan, MD
Hitit Universirty
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 29, 2023
First Posted
January 23, 2024
Study Start
January 31, 2024
Primary Completion
May 20, 2024
Study Completion
August 15, 2024
Last Updated
January 6, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share
not necessary